Try
Amneal Pharmaceuticals Inc. Class A Common Stock
AMRXUnited States
49 filed reports · 673 financial concepts · 1 earnings calls · 5 media appearances
Filed reports
49 reports · Dec 2017 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 104 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 26 | 6,661 | Mar 2018 to Jun 2026 |
| Current · 8-KSEC EDGAR | 14 | 102 | Mar 2018 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 9 | 5,724 | Dec 2017 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 504 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Jul 30, 2026 | 6 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 354 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 27, 2026 | 1,306 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 398 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 229 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 7, 2025 | 235 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 28, 2025 | 616 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 12, 2024 | 290 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 9, 2024 | 249 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 8, 2024 | 251 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Mar 14, 2024 | 725 | Open |
Financial data
673 concepts · 12,487 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial622 concepts · 9,490 facts · Dec 2016 to Jul 2026
- Revenue49 · Dec 2016 to Jun 2026
- Cash and cash equivalents at carrying value48 · Dec 2016 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents48 · Dec 2016 to Jun 2026
- Gross profit (US GAAP)48 · Dec 2016 to Jun 2026
- Net income loss48 · Dec 2016 to Jun 2026
- Net income loss available to common stockholders basic48 · Dec 2016 to Jun 2026
- Profit loss48 · Dec 2016 to Jun 2026
- Amortization of intangible assets47 · Dec 2016 to Jun 2026
- Comprehensive income net of tax47 · Dec 2016 to Jun 2026
- Cost of goods and services sold (US GAAP)47 · Dec 2016 to Jun 2026
- Foreign currency transaction gain loss before tax47 · Dec 2016 to Jun 2026
- Income tax expense benefit47 · Dec 2016 to Jun 2026
- Interest income expense nonoperating net47 · Dec 2016 to Jun 2026
- Net income loss attributable to noncontrolling interest47 · Dec 2016 to Jun 2026
- Nonoperating income expense47 · Dec 2016 to Jun 2026
- Operating income loss47 · Dec 2016 to Jun 2026
- Other comprehensive income loss net of tax portion attributable to parent47 · Dec 2016 to Jun 2026
- Other nonoperating income expense47 · Dec 2016 to Jun 2026
- Research and development expense47 · Dec 2016 to Jun 2026
- Restricted cash and cash equivalents at carrying value47 · Dec 2016 to Jun 2026
- Restructuring charges47 · Dec 2016 to Jun 2026
- Selling general and administrative expense47 · Dec 2016 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect46 · Dec 2016 to Jun 2026
- Depreciation and amortization46 · Dec 2016 to Jun 2026
Segment42 concepts · 2,768 facts · Dec 2016 to Jun 2026
- Revenue1,031 · Dec 2016 to Jun 2026
- Cost of goods and services sold (US GAAP)135 · Dec 2016 to Jun 2026
- Gross profit (US GAAP)134 · Dec 2016 to Jun 2026
- Operating income loss134 · Dec 2016 to Jun 2026
- Research and development expense134 · Dec 2016 to Jun 2026
- Selling general and administrative expense134 · Dec 2016 to Jun 2026
- Goodwill124 · Jun 2018 to Jun 2026
- Restructuring charges122 · Dec 2016 to Jun 2026
- Gain loss related to litigation settlement114 · Dec 2016 to Jun 2026
- Royalty expense85 · Dec 2017 to Sep 2024
- Acquisition, transaction-related and integration expenses61 · Dec 2016 to Dec 2022
- Other operating income expense net60 · Sep 2022 to Jun 2026
- Operating Segments56 · Sep 2018 to Jun 2026
- Asset impairment charges54 · Sep 2018 to Dec 2023
- Cost of goods sold impairment charges43 · Sep 2018 to Dec 2022
- Fair value measurement with unobservable inputs reconciliation recurring basis liability gain loss included in earnings43 · Dec 2021 to Dec 2024
- Goodwill foreign currency translation gain loss35 · Dec 2023 to Jun 2026
- Legal fees26 · Dec 2016 to Sep 2019
- Operating Income26 · Sep 2017 to Jun 2026
- SG&A Expense26 · Sep 2017 to Jun 2026
- Cost of Goods and Services Sold25 · Sep 2018 to Jun 2026
- Gross Profit25 · Sep 2018 to Jun 2026
- R&D Expense25 · Sep 2018 to Jun 2026
- Business combination contingent consideration arrangements change in amount of contingent consideration liability122 · Sep 2021 to Mar 2023
Product3 concepts · 119 facts · Dec 2016 to Dec 2023
- Revenue104 · Dec 2016 to Dec 2019
- Cost of goods and services sold (US GAAP)14 · Dec 2016 to Dec 2023
- Inventory1 · Sep 2019
Guidance5 concepts · 104 facts · May 2018 to Aug 2026
- Capital Expenditures Guidance28 · May 2018 to Aug 2026
- EPS (Diluted) Guidance26 · May 2018 to Jul 2026
- Gross Margin Guidance22 · May 2018 to Nov 2020
- Effective Tax Rate Guidance14 · May 2018 to Nov 2019
- Revenue Guidance14 · Feb 2020 to Jul 2026
Geography1 concepts · 6 facts · Dec 2017 to Dec 2019
- Revenue6 · Dec 2017 to Dec 2019
Segments
2,893 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments15 members · 2,768 facts
- Generics820 · Dec 2016 to Mar 2026
- Av KARE534 · Mar 2020 to Jun 2026
- Amneal Specialty Pharma459 · Jun 2017 to Jun 2026
- Affordable Medicines312 · Dec 2022 to Jun 2026
- Specialty309 · Dec 2016 to Jun 2026
- Amneal specialty pharma segment133 · Jun 2018 to Jun 2026
- Av Kare44 · Dec 2018 to Dec 2021
- Amneal Generics37 · Jun 2017 to Sep 2018
- Generics segment36 · Dec 2018 to Mar 2026
- Av karesegment32 · Mar 2020 to Jun 2026
- Specialty segment28 · Dec 2018 to Mar 2024
- Amneal generics segment10 · Sep 2017 to Sep 2018
- Generic segment6 · Mar 2020 to Sep 2021
- Affordable medicines segment5 · Dec 2023 to Jun 2026
- Amneal specialty pharma segment3 · Dec 2023 to Dec 2025
Product or service27 members · 119 facts
- Diclofenac Sodium Gel14 · Dec 2016 to Sep 2019
- Shipping And Handling14 · Dec 2016 to Dec 2023
- Yuvafem Estradiol13 · Dec 2016 to Jun 2019
- Aspirin Dipyridamole ER Capsul10 · Jun 2017 to Dec 2018
- Epinephrine Auto Injector Family Generic Adrenaclick8 · Jun 2018 to Sep 2019
- Rytary Family8 · Jun 2018 to Sep 2019
- Anti Infective3 · Dec 2017 to Dec 2019
- Antiviral3 · Dec 2017 to Dec 2019
- Cardiovascular System3 · Dec 2017 to Dec 2019
- Central Nervous System3 · Dec 2017 to Dec 2019
- Dermatology3 · Dec 2017 to Dec 2019
- Gastroenterology3 · Dec 2017 to Dec 2019
- Hormonal Allergy3 · Dec 2017 to Dec 2019
- Levothyroxine Sodium3 · Mar 2019 to Sep 2019
- Metabolic Disease Endocrine3 · Dec 2017 to Dec 2019
- Oncology3 · Dec 2017 to Dec 2019
- Oseltamivir3 · Sep 2017 to Mar 2018
- Product And Service Other3 · Dec 2017 to Dec 2019
- Respiratory3 · Dec 2017 to Dec 2019
- Royalties3 · Dec 2017 to Dec 2019
- Atovaquone2 · Jun 2017 to Mar 2018
- Lidocaine2 · Dec 2016 to Sep 2017
- Ranitidine2 · Jun 2017 to Dec 2017
- Ranitidine1 · Sep 2019
- Metaxalone1 · Dec 2016
- Metformin ER1 · Dec 2016
- Oxymorphone1 · Sep 2019
Statement geographical2 members · 6 facts
- Non Us3 · Dec 2017 to Dec 2019
- US3 · Dec 2017 to Dec 2019
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary107 claims from 11 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary185 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes16 claims from 1 reports · Dec 2025
- Risk factors113 risks from 2 annual reports · 2024 to 2025
Earnings calls
1 calls · Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 30, 2026
Executive media
5 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- TV interviews2 · Mar 2023 to Oct 2024
- Conference talks1 · Dec 2025
- Other appearances1 · Jun 2021
- Podcasts1 · Sep 2023
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.